|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kent A: HPV vaccination and testing. Rev
Obstet Gynecol. 3:33–34. 2010.PubMed/NCBI
|
|
6
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martin CM, Astbury K and O'Leary JJ:
Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn.
6:217–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:pp. 15524–15529. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Hong W, Zhou C, Jiang Z, Wang G,
Wei G and Li X: miR-539 inhibits FSCN1 expression and suppresses
hepatocellular carcinoma migration and invasion. Oncol Rep.
37:2593–2602. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Z, Wang M, He Q, Li Z, Zhao Y, Wang
W, Ma J, Li Y and Chang G: MicroRNA-98 rescues proliferation and
alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1.
Exp Ther Med. 13:1702–1710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu Y, Wu G, Yan W, Zhan H and Sun P:
miR-146b-5p regulates cell growth, invasion, and metabolism by
targeting PDHB in colorectal cancer. Am J Cancer Res. 7:1136–1150.
2017.PubMed/NCBI
|
|
13
|
Liao J, Lin J, Lin D, Zou C, Kurata J, Lin
R, He Z and Su Y: Down-regulation of miR-214 reverses erlotinib
resistance in non-small-cell lung cancer through up-regulating LHX6
expression. Sci Rep. 7:7812017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu B, Tian Y, Li F, Zhao Z, Jiang X, Zhao
C, Han X and Zhang L: Tumor-suppressing roles of miR-214 and
miR-218 in breast cancer. Oncol Rep. 35:3178–3184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu G, Wang J, Xu K and Dong J: Dynamic
regulation of uncoupling protein 2 expression by microRNA-214 in
hepatocellular carcinoma. Biosci Rep. 36(pii): e003352016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Q, Xu L, Li C, Yuan Y, Huang S and Chen
H: MiR-214 inhibits invasion and migration via downregulating
GALNT7 in esophageal squamous cell cancer. Tumor Biol.
37:14605–14614. 2016. View Article : Google Scholar
|
|
17
|
Zhang Q and Zhang S: MiR-214 promotes
radioresistance in human ovarian cancer cells by targeting PETN.
Biosci Rep. 27:BSR201703272017. View Article : Google Scholar
|
|
18
|
Margueron R and Reinberg D: The Polycomb
complex PRC2 and its mark in life. Nature. 469:343–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Croce L and Helin K: Transcriptional
regulation by Polycomb group proteins. Nat Struct Mol Biol.
20:1147–1155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kleer CG, Cao Q, Varambally S, Shen R, Ota
I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, et al: EZH2
is a marker of aggressive breast cancer and promotes neoplastic
transformation of breast epithelial cells. Proc Natl Acad Sci USA.
100:pp. 11606–11611. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2011.
View Article : Google Scholar
|
|
23
|
Yang LH, Yin SY, He RQ, Mo WJ, Pang YY, Wu
YZ, Peng ZG and Gan TQ: Prospective target genes and pathways of
miR-30a-5p in colorectal cancer: An investigation using TCGA and
bioinformatics analysis. Int J Clin Exp Med. 10:4373–4385.
2017.
|
|
24
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2017. View Article : Google Scholar
|
|
25
|
Yang Z, Chen S, Luan X, Li Y, Liu M, Li X,
Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical
cancers and inhibits the growth of HeLa cells. IUBMB Life.
61:1075–1082. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao X, Lu C, Chu W, Zhang Y, Zhang B,
Zeng Q, Wang R, Li Z, Lv B and Liu J: microRNA-214 governs lung
cancer growth and metastasis by targeting carboxypeptidase-D. DNA
Cell Biol. 35:715–721. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peng R, Men J, Ma R, Wang Q, Wang Y, Sun Y
and Ren J: miR-214 down-regulates ARL2 and suppresses growth and
invasion of cervical cancer cells. Biochem Biophys Res Commun.
484:623–630. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang JM, Ju BH, Pan CJ, Gu Y, Li MQ, Sun
L, Xu YY and Yin LR: MiR-214 inhibits cell migration, invasion and
promotes the drug sensitivity in human cervical cancer by targeting
FOXM1. Am J Transl Res. 9:3541–3557. 2017.PubMed/NCBI
|
|
29
|
Chandrasekaran KS, Sathyanarayanan A and
Karunagaran D: MicroRNA-214 suppresses growth, migration and
invasion through a novel target, high mobility group AT-hook 1, in
human cervical and colorectal cancer cells. Br J Cancer.
115:741–751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Y, Liu T, Bao X, He M, Li L and Yang
X: Increased EZH2 expression is associated with proliferation and
progression of cervical cancer and indicates a poor prognosis. Int
J Gynecol Pathol. 33:218–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Juan AH, Kumar RM, Marx JG, Young RA and
Sartorelli V: Mir-214-dependent regulation of the polycomb protein
Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell.
36:51–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao M, Liu Y, Chen Y, Yin C, Chen JJ and
Liu S: miR-214 protects erythroid cells against oxidative stress by
targeting ATF4 and EZH2. Free Radic Biol Med. 92:39–49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu WS, Tang CM, Xiao Z, Zhu JN, Lin QX,
Fu YH, Hu ZQ, Zhang Z, Yang M, Zheng XL, et al: Targeting EZH1 and
EZH2 contributes to the suppression of fibrosis-associated genes by
miR-214-3p in cardiac myofibroblasts. Oncotarget. 7:78331–78342.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang T, Zhang GF, Chen XF, Gu HH, Fu SZ,
Xu HF, Feng Q and Ni YM: MicroRNA-214 provokes cardiac hypertrophy
via repression of EZH2. Biochem Biophys Res Commun. 436:578–584.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu C, He T, Li Z, Liu H and Ding B:
Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth,
migration and invasion of glioma cells. Biomed Pharmacother.
95:1504–1513. 2017. View Article : Google Scholar : PubMed/NCBI
|
